Evidence map›Paper›PMID 27588705›Full record

ArticleCell death and differentiation2016

Thrombospondin 1 protects pancreatic β-cells from lipotoxicity via the PERK-NRF2 pathway.

Daniel A Cunha, Monia Cito, Per-Ola Carlsson, Jean-Marie Vanderwinden, Jeffery D Molkentin, Marco Bugliani, Piero Marchetti, Décio L Eizirik, Miriam Cnop

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Emerging functions of thrombospondin-1 in immunity.Seminars in cell & developmental biology · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CD47 and thrombospondin-1 regulation of mitochondria, metabolism, and diabetes.American journal of physiology. Cell physiology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Daniel A CunhaULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Monia CitoULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Per-Ola CarlssonDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
Jean-Marie VanderwindenLight Microscopy Facility, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Jeffery D MolkentinDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Marco BuglianiDepartment of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Piero MarchettiDepartment of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.
Décio L EizirikULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Miriam CnopULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Université Libre de Bruxelles · BEUniversity of Pisa · ITCincinnati Children's Hospital Medical Center · USUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The failure of β-cells has a central role in the pathogenesis of type 2 diabetes, and the identification of novel approaches to improve functional β-cell mass is essential to prevent/revert the disease. Here we show a critical novel role for thrombospondin 1 (THBS1) in β-cell survival during lipotoxic stress in rat, mouse and human models. THBS1 acts from within the endoplasmic reticulum to activate PERK and NRF2 and induce a protective antioxidant defense response against palmitate. Prolonged palmitate exposure causes THBS1 degradation, oxidative stress, activation of JNK and upregulation of PUMA, culminating in β-cell death. These findings shed light on the mechanisms leading to β-cell failure during metabolic stress and point to THBS1 as an interesting therapeutic target to prevent oxidative stress in type 2 diabetes.

Indexed as

AnimalsAntioxidantsApoptosis Regulatory ProteinsCell SurvivalCytoprotectioneIF-2 KinaseEndoplasmic ReticulumEndoplasmic Reticulum StressFemaleHumansInsulin-Secreting CellsJNK Mitogen-Activated Protein KinasesLipidsMaleMiceMiddle AgedAntioxidantsApoptosis Regulatory ProteinseIF-2 KinaseJNK Mitogen-Activated Protein KinasesLipidsNF-E2-Related Factor 2Palmitic AcidThrombospondin 1

Identifiers

PMID27588705
PMCPMC5136495
OpenAlexW2513897763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.